The Russian Ministry of Health announced that a third vaccine against Covid-19, labelled CoviVac.
The CoviVac vaccine against the novel coronavirus infection has demonstrated its efficacy and safety during clinical trials, Russian Healthcare Minister Mikhail Murashko told journalists.
Earlier, Russian Prime Minister Mikhail Mishustin said that the vaccine was officially registered. According to him, the first 120,000 doses of CoviVac will enter civilian circulation in the middle of March, (TASS) news agency said.
"The Russian Healthcare Ministry made a decision to register the third Russian CoviVac vaccine developed by the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products. During clinical trials on volunteers the vaccine demonstrated safety and efficacy. Its large-scale studies will continue during the post-registration phase," the minister said.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Russia, China ‘thwarting global response to Myanmar crisis’
Volcano erupts in southern Caribbean, sparking evacuation 'frenzy'
Myanmar military refuses entry to UN special envoy
Armed clashes break out in Myanmar between troops and anti-junta protesters
New Zealand suspends entry for travellers from India due to high Covid-19 cases
Myanmar activists stage ‘red’ protest
Pope expresses solidarity with Myanmar youth
Myanmar junta hunts critics, 5 killed in firing
Junta says Suu Kyi broke secrets law, Britain ramps up sanctions